DaVita has underperformed the broader market over the past year, and analysts are cautious about the stock’s prospects.

Shares of dialysis provider DaVita Inc. (NYSE:DVA) fell 8.5% in the afternoon session after the company reported a decline in ...

Shares of DaVita Inc. DVA advanced 1.42% to $129.50 Friday, on what proved to be an all-around great trading session for the ...

US healthcare company DaVit has revealed it suffered a ransomware attack and a data breach earlier this year which saw ...

DaVita has notified over 1 million individuals that their personal and health information was stolen in a ransomware attack.

Q2 2025 Earnings Call Transcript August 5, 2025 DaVita Inc. beats earnings expectations. Reported EPS is $2.95, expectations ...

DaVita fell victim to a cyberattack back in March of this year during which time hackers gained unauthorized access to its ...

Akebia Therapeutics reports strong Q2 2025 earnings, driven by Vafseo’s 55% sales growth. Explore plans for expanded patient access & trial updates.

Learn more about whether Alignment Healthcare, Inc. or DaVita Inc. is a better investment based on AAII's A+ Investor grades, ...

Gain insights into DaVita Inc.'s Q2 2025 earnings call. Explore volume challenges, cost controls, cyber incident impact, and reaffirmed financial guidance.

According to a regulatory filing late Monday, Berkshire Hathaway sold approximately 1.64 million shares of DaVita Inc. on ...

DaVita beat Wall Street estimates for second-quarter profit on Tuesday, driven by demand for its kidney dialysis services.